CaixaBank, S.A.’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
KCM
CaixaBank, S.A.'s ELTX Position: Q3 2026 in Review
CaixaBank, S.A. held its Elicio Therapeutics (ELTX) position steady in Q3 2026 at 6,600 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #466.
CaixaBank, S.A. first reported a position in ELTX in Q3 2025 and has held it in 5 quarters since. The position peaked at $70.6K in Q1 2026. 78 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.
- CaixaBank, S.A. held 6,600 shares of Elicio Therapeutics worth $12K as of Q3 2026.
- CaixaBank, S.A. left its Elicio Therapeutics share count unchanged in Q3 2026.
- Elicio Therapeutics made up ﹤0.01% of CaixaBank, S.A.'s portfolio in Q3 2026, its #466 holding.
- CaixaBank, S.A. first reported a position in Elicio Therapeutics in Q3 2025 and has held it in 5 quarters since.
- CaixaBank, S.A.'s Elicio Therapeutics position peaked at $70.6K in Q1 2026.
- 78 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.
Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.